cd34+ cells transduced with ada retrovir
Cell therapyexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 20, 2001 (NCT00018018)
Timeline
2000s
- Jan 1, 2001
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Adenosine deaminaseSupplementation
ADA supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cd34+ cells transduced with ada retrovir
- cd34+ cells transduced with a human ada gene
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00018018 | Phase 1 | Jun 20, 2001 | National Human Genome Research Institute (NHGRI) |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Human Genome Research Institute (NHGRI) | Government | 1 | 1 | 1 | 2001 |
1 organizations
Page 1 / 1